| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,189 |
4,091 |
$225K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,586 |
1,376 |
$40K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
623 |
539 |
$23K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
175 |
158 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,003 |
912 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
341 |
319 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
1,222 |
1,118 |
$2K |
| 87428 |
|
29 |
25 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
29 |
25 |
$568.32 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
18 |
16 |
$366.93 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
97 |
78 |
$246.29 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
131 |
117 |
$203.20 |
| 80305 |
|
43 |
37 |
$179.52 |
| 99497 |
|
13 |
13 |
$13.43 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
41 |
30 |
$3.15 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
16 |
15 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
17 |
16 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
20 |
17 |
$0.00 |